Skip to main navigation Skip to search Skip to main content

Upconverting nanoparticles for high contrast breast cancer biomarker imaging

  • University College Cork
  • Lumito AB

Research output: Chapter in Book/Report/Conference proceedingsConference proceedingpeer-review

Abstract

We report high contrast upconverting nanoparticles labeling of human epidermal growth factor receptor 2 in control pellet arrays and breast cancer tissue. A Fourier transform-based algorithm provided semi-quantitative tissue assessment tool with high background-to-noise ratio.

Original languageEnglish
Title of host publicationFrontiers in Optics
Subtitle of host publicationProceedings Frontiers in Optics + Laser Science 2023, FiO, LS 2023
PublisherOptical Society of America
ISBN (Electronic)9781957171296
DOIs
Publication statusPublished - 2023
EventFrontiers in Optics + Laser Science 2023, FiO, LS 203: Part of Frontiers in Optics + Laser Science 2023 - Tacoma, United States
Duration: 9 Oct 202312 Oct 2023

Publication series

NameFrontiers in Optics: Proceedings Frontiers in Optics + Laser Science 2023, FiO, LS 2023

Conference

ConferenceFrontiers in Optics + Laser Science 2023, FiO, LS 203: Part of Frontiers in Optics + Laser Science 2023
Country/TerritoryUnited States
CityTacoma
Period9/10/2312/10/23

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Upconverting nanoparticles for high contrast breast cancer biomarker imaging'. Together they form a unique fingerprint.

Cite this